Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
April-2016 Volume 11 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
April-2016 Volume 11 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Changes in mitotic reorientation and Wnt/AR signaling in rat prostate epithelial cells exposed to subchronic testosterone

  • Authors:
    • Xiangyun Liu
    • Yi Cheng
    • Qi Pan
    • Wenjuan Hu
    • Li Xu
    • Xiang Meng
    • Jianhui Wu
    • Chenjing Xie
    • Han Yan
    • Zuyue Sun
  • View Affiliations / Copyright

    Affiliations: Key Laboratory of Exercise and Health Sciences (Shanghai University of Sport), Ministry of Education, Shanghai 200438, P.R. China, Laboratory Testing Division, WuXi AppTec (Shanghai) Co., Ltd., Shanghai 200131, P.R. China, Department of Pharmacology and Toxicology, Shanghai Institute of Planned Parenthood Research, Shanghai 200032, P.R. China, Department of Pharmacy, Shanghai Children's Hospital, Shanghai Jiatong University, Shanghai 200040, P.R. China
  • Pages: 1361-1366
    |
    Published online on: February 1, 2016
       https://doi.org/10.3892/etm.2016.3044
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

The aim of the present study was to investigate the changes in mitotic reorientation and relative differential gene expression in rat prostate epithelial cells following long‑term exposure to testosterone propionate (TP). Sprague‑Dawley rats were randomly divided into two groups as follows: TP group, which received 3.7 mg/kg/day TP for 30 days (n=10); and control group, in which rats were injected with olive oil (n=10). Microscopic analysis of the prostate tissue was performed by immunohistochemical analysis and hematoxylin and eosin staining. Differential gene expression analysis was performed via gene microarray, and a total of five genes (Dkk3, Ran, Fas, Tgm4 and Wnt2) were selected and their expression levels were verified using reverse transcription‑polymerase chain reaction. For rats treated with TP, mitosis was significantly reoriented, becoming parallel to the basement membrane. By contrast, in the control group cells mitotic orientation remained perpendicular to the basement membrane. Genes such as Ran and Tgm4 in the androgen receptor (AR) signaling pathway and Wnt2 in the Wnt signaling pathway, were upregulated following treatment with TP. Conversely, the Dkk3 and Fas genes were downregulated following treatment with TP. In conclusion, mitotic orientation of prostate epithelial cells was altered following long‑term administration of TP. Wnt and AR signaling pathways influenced cell proliferation and may have participated in the mitotic orientation change.

Introduction

Testosterone propionate (TP) is known to serve a crucial function in benign prostatic hyperplasia (BPH) and prostatic carcinoma (Pca). Pca is common in the developed world and is the most prevalent cancer among men in the USA. BPH is also a common disease in men >50 years of age (1). However, the mechanisms through which TP affects these processes are not clear. Mitotic orientation is generally perpendicular to the basement membrane in the glandular epithelium of control castrated rats; however, a recent study observed that mitotic orientation was parallel to the basement membrane in the glandular epithelium of castrated rats treated with TP (2).

TP is a sex hormone that primarily activates the androgen receptor (AR) (3), a key regulatory protein that is a critical intermediate in the intracellular androgen pathway (4). Chronic androgen stimulation may promote the expression and secretion of AR from epithelial cells. Additionally, prostate basal tissue may contain stem cells, and the aging and molecular injury mechanisms in stem cells are crucially involved in the development of age-associated diseases, such as BPH and cancer (5). Prostate basal cells are not dependent on androgen; however, the presence of androgen is able to induce the proliferation and differentiation of prostate basal cells (6), which is a key mechanism for the induction of prostate cell proliferation.

In order to elucidate the details of the mechanism(s) involved in changes in mitotic orientation in the prostatic glandular epithelium of castrated rats exposed to subchronic TP and the associated differential gene expression, an animal model was established in Sprague-Dawley (SD) rats (2). The aim of the present study was to determine the changes in mitotic orientation in SD rats that received long-term TP exposure and to compare the differences in gene expression between TP-treated and control rats using gene microarrays. In addition, the role of the Wnt and AR signal transduction pathways in prostate cell proliferation was evaluated by determining the expression of a number of associated genes.

Materials and methods

Experimental animals

A total of 20 male 4-month-old SD rats [certificate no. SCXK 2003-0002] were obtained from Shanghai Laboratory Animal Center of Chinese Academy Science (Shanghai, China) and housed in a specific pathogen-free room (temperature, 20–26°C; humidity, 40–70%), with free access to water and food. All procedures and animal experiments were approved by the Animal Ethical Committee of Shanghai Institute of Planned Parenthood Research (Shanghai, China) and complied with the Animal Management Rules of the Chinese Ministry of Health (document no. 55, 2001).

Establishment of a rat model for BPH

Castrated rats were treated with subcutaneous injection of TP for 30 days at a dose of 3.7 mg/kg/day (n=10). Rats in the control group (n=10) were treated with an equivalent volume of olive oil (100 µl). The prostate from each test and control rat was removed following the final treatment. All tissue specimens were removed under anesthesia (3% Nembutal, 0.2 ml/100 ml; Sigma-Aldrich, St. Louis, MO, USA), and the specimens were fixed in formaldehyde solution and processed in paraffin. Paraffin blocks were cut into 5-µm sections for hematoxylin and eosin (H&E) and immunohistochemical staining.

Immunohistochemical staining procedure

Expression of AR was detected in prostate cells using immunohistochemical staining. Following deparaffination and rehydration of the sections, slides were placed in sodium citrate solution (0.01 M, pH 6.0) and heated to 96–100°C for 25 min. After cooling, sections were incubated in 5% bovine serum albumin (Beijing Zhongshan Biological Technology Co., Ltd., Beijing, China) for 20 min. The sections were then incubated for 2 h with primary rabbit anti-mouse AR monoclonal antibody (1:100; cat. no. BA0004; Wuhan Boster Biotechnology, Ltd., Wuhan, China) diluted to 1:100 in phosphate-buffered saline (PBS) at room temperature. Following primary incubation, the sections were washed in PBS three times and incubated with horseradish peroxidase-conjugated goat anti-rabbit secondary antibody (1:50; cat. no. BA1051; Wuhan Boster Biolotechnology Co., Ltd.) for 30 min at 37°C. Subsequently, the sections were washed with PBS and subjected to treatment with 3,3′-diaminobenzidine color-substrate solution and placed under cover slips. AR-labeled cells were observed using an Eclipse 50i light microscope (Nikon Corporation, Tokyo, Japan) in bright field mode.

Orientation of mitosis

For prostate epithelial cells, a parallel orientation was defined as the alignment of the chromosome axis and basement membrane at a 0–45° angle. By contrast, a perpendicular orientation was defined as the alignment of the chromosome axis and the basement membrane at a 45–90° angle. The cells were observed and imaged using the Nikon Eclipse 50i optical microscope, as described in a previous study (2).

Evaluation of differential gene expression by rat genome microarray analysis

Evaluation of differential gene expression was conducted using the Rat Genome 230 2.0 Array (Affymetrix, Inc., Santa Clara, CA, USA), which provides comprehensive coverage of the transcribed rat genome: 31,000 probe sets analyze the expression level of >30,000 transcripts and variants from >28,000 known rat genes. Total RNA was extracted using TRIzol reagent (Ambion; Thermo Fisher Scientific, Inc., Foster City, CA, USA) and its quality was confirmed using agarose-formaldehyde (Beijing Zhongshan Biological Technology Co., Ltd.) (7). Subsequently, double-stranded cDNA was synthesized from 5 µg total RNA using the One-Cycle cDNA Synthesis kit (Affymetrix, Inc.), according to the manufacturer's instructions. Biotin-labeled cRNA was transcribed from the cDNA using the GeneChip® IVT Labeling kit (Affymetrix, Inc.). Labeled cRNA (15 µg) was then fragmented and hybridized to the Affymetrix Rat Genome 230 2.0 Array for 16 h at 45°C in an Affymetrix GeneChip® Hybridization Oven 640 (Affymetrix, Inc.). The hybridized array was washed and stained in the GeneChip® Fluidics Station 450 (Affymetrix, Inc.), and fluorescent signals were detected using the Affymetrix GeneChip® Scanner 3000 (Affymetrix, Inc.). These data were initially documented with Affymetrix GeneChip® operating software GCOS 1.2 (Affymetrix, Inc.), which generated an expression report file.

Reverse transcription-polymerase chain reaction (RT-PCR) analysis of gene expression

Total RNA prepared for microarray analysis was also used for RT-PCR analysis. Total RNA (2 µg) from each sample was subjected to reverse transcription using a Superscript First-Strand cDNA Synthesis kit (Henan Huamei Bioengineering Co., Ltd., Henan, China) according to the manufacturer's instructions. PCR was subsequently conducted by mixing 1 µl cDNA, 2.5 µl 10X PCR buffer, 1.5 µl 25 mM MgCl2, 2.5 µl 2.5 mM dNTP, 1 µl 10 µM specific gene primer pairs, 1 µl 10 µM β-actin or GAPDH primer pairs, 25 µl H2O and 1 U Taq polymerase (Ambion; Thermo Fisher Scientific, Inc.). The primers used in the PCR reaction are presented in Table I. PCR products were then amplified for 30 cycles, with each cycle consisting of the following steps: Denaturation for 10 sec at 95°C, annealing for 20 sec at 72°C and polymerization for 5 min at 72°C. The PCR products were resolved using an Affymetrix Hybridization Oven Model 640 (model 800138; Affymetrix, Inc.) according to a DNA standard curve. Data were analyzed using Light Cycler 480 software version 1.5 (Roche Diagnostics, Basel, Switzerland).

Table I.

Primers used in reverse transcription-polymerase chain reaction.

Table I.

Primers used in reverse transcription-polymerase chain reaction.

GeneBidirectional primer sequenceAnnealing temperature (°C)Product length (bp)
β-actinF: 5′-CCTCTATGCCAACACAGTGC-3′58211
R: 5′-GTACTCCTGCTTGCTGATCC-3′
RanF: 5′-CGTAGACGGTAAAGCAATGG-3′59149
R: 5′-AGTCAAAGAAGCAGCAAACAC-3′
Dkk3F :5′-ACACCCAACAAGAAGCAACC-3′59174
R: 5′-AGGGAAAGAGGGAGAAAGC-3′
FasF: 5′-GACAACAACTGCTCAGAAGG-3′59105
F: 5′-TCAGAATAGTGTTTCCTGTCC-3′
Tgm4F: 5′-CGAGAACAGGCGTCAAGATA-3′59246
R: 5′-GTCTGTAGGTCAAGGGAGCAT-3′
Wnt2F: 5′-GTGCCGACTGGACAACTCCT-3′59224
R: 5′-ACCTCAGAATGCCCAAGACA-3′

[i] F, forward; R, reverse.

Statistical analysis

Data were expressed as the mean ± standard deviation. One-way analysis of variance (ANOVA) and P-values were used to evaluate significant differences between the groups. Image-Pro Plus 6.0 (Media Cybernetics, Inc., Rockville, MD, USA) was used to analyze image data. Data analysis to determine differential gene expression profiles was performed by importing MAS 5.0 intensity data (Affymetrix, Inc.) into the Partek Genomics Suite Version 6.4 (Partek Incorporated, St. Louis, MO) for ANOVA based on time in culture. P<0.05 was considered to indicate a statistically significant difference. Post-hoc Fisher's exact test adjusted to correct for false discovery rates (P<0.05) was used to compare data from multiple groups. Only differentially expressed genes (−2.0 > fold-change >2.0; P<0.05) were included in each IPA core analysis.

Results

Mitotic orientation of prostate epithelia in rats

Prostate epithelia from TP-treated rats exhibited typical prostate proliferation morphology, in which the organ quotient, volume and area of the prostate glandular cavity were increased compared with the control group. H&E staining revealed that the prostate epithelia were highly stylolitic, with intrusions in the glandular cavity, and the area of the prostate glandular cavity was large (Fig. 1). The mitotic orientation of prostate epithelial cells in TP-treated rats was parallel to the basement membrane, while the orientation in the control rats was perpendicular to the basement membrane (Fig. 2). These data demonstrate that the mitotic orientation of prostate epithelial cells changed following long-term exposure to TP.

Figure 1.

Prostate epithelia of the (A) control and (B) TP groups, stained with hematoxylin and eosin. Compared with the control group, the area of the prostate glandular cavity was significantly different in rats exposed to TP (magnification, ×10). TP, testosterone propionate.

Figure 2.

Mitotic orientation of prostate epithelia in the (A) control and (B) TP groups. Mitotic orientation of the prostate epithelium in the control group was perpendicular to the basement membrane, while that of the TP group was parallel to the basement membrane (magnification, ×400). TP, testosterone propionate.

Analysis of AR expression

Notably, immunohistochemical staining revealed an increased number of AR-positive cells in the prostate epithelia of the TP-treated rats when compared with the control rats (Fig. 3), indicating that TP treatment upregulated AR expression.

Figure 3.

Analysis of AR expression in the (A) control and (B) TP groups. Brown-colored cells were positively stained for AR. Few AR-positive cells were seen in the control group, whereas increased AR staining was observed in the prostate glandular epithelia of the TP-treated rats (magnification, ×100). AR, androgen receptor; TP, testosterone propionate.

Results of gene chip microarray analysis

A rat genome microarray technique was used to analyze the differences in gene expression between the control and TP-treated rats. Genes that were altered in the TP group were assumed to be associated with changes in prostate cell mitotic orientation and proliferation. A number of the differentially expressed genes were associated with the AR and Wnt signal transduction pathways (Table II). Upregulation was observed in genes that promote cellular proliferation, including Ran, Tgm4, Odc1 and Wnt2, while downregulation was observed in genes that inhibit cell proliferation, such as Dkk3 and Fas.

Table II.

Wnt- and AR-associated genes that were up- or downregulated following testosterone propionate treatment in rats.

Table II.

Wnt- and AR-associated genes that were up- or downregulated following testosterone propionate treatment in rats.

Probe IDGeneCharacter and functionRegulation
AT 1367590RanAR-associated proteinUp
AT 1371022Tgm4Pca-associated geneUp
AT 1393927Wnt2Wnt signaling transduced elementUp
AT 1370328Dkk3Negative regulation element of WntDown
AT 1397221FasApoptosisDown
AT 1370163Odc1Cell cycle controlUp
AT 1370235DbiGABA receptor regulation factorUp
AT 1371150tCcnd1Cell cycle controlUp
AT 1368785Pitx2Transcription regulation factorDown
AT 1369788JunTranscription regulation factorDown

[i] AR, androgen receptor; Pca, prostatic carcinoma; GABA, γ-aminobutyric acid.

RT-PCR analysis of selected genes

To confirm the observed changes in gene expression, RT-PCR analysis was performed for a number of the genes, including Dkk3, Ran, Fas, Tgm4 and Wnt2 (Table III). The results of RT-PCR analysis were consistent with the microarray data.

Table III.

Reverse transcription-polymerase chain reaction analysis of the five selected genes and β-actin.

Table III.

Reverse transcription-polymerase chain reaction analysis of the five selected genes and β-actin.

GeneControlTP
β-actin 1.95×10−3 2.66×10−3
Dkk3 2.93×10−4 1.18×10−5
Ran 1.07×10−4 2.37×10−4
Fas 9.47×10−4 8.85×10−6
Tgm4 1.09×10−4 2.46×10−3
Wnt2 1.24×10−3 1.44×10−4

[i] TP, testosterone propionate.

Discussion

To the best of our knowledge, the present study showed for the first time that the mitotic orientation of rat prostate epithelial cells changes following exposure to TP for an extended period. In addition, a microarray analysis of over 28,000 rat genes, followed by verification using RT-PCR, indicated that the Wnt and AR signal transduction pathways were involved in the observed changes in the mitotic orientation of prostate epithelial cells in response to TP treatment.

The present study revealed that the mitotic orientation of rat prostate epithelial cells is altered following cell exposure to TP, providing a new method for the study of TP-dependent prostate cell proliferation. Additionally, the immunohistochemistry and H&E results of previous studies demonstrated that the prostate may be a target organ for TP (8,9). Therefore, changes in cell proliferation may result from the reorientation of the mitotic complex following exposure of the prostate to TP. In a previous study, in control cells, mitotic orientation was parallel to the basement membrane; therefore, changes in proliferation may occur via the AR signal transduction pathway (10).

In the present study, TP-treated rats exhibited upregulation of Wnt2 and other positive regulatory genes, while negative regulatory genes, such as Dkk3, were downregulated compared with the control group. The Wnt pathway has been widely studied (11,12), and is crucially involved in numerous proliferative diseases, such as Pca. In the classical Wnt signaling pathway, Wnt2 stimulates cell proliferation and regulates the aging process of fibroblasts and epithelial cells. In addition, Wnt2 signal reduction has been observed in senescent cells (13). Increased expression of Wnt2 is able to stimulate prostate epithelial cell proliferation, activate the Wnt signaling pathway and cause changes in prostate epithelial cell polarity (13), which may result in chromosomal changes in prostate epithelial cells.

Dkk3 is a member of the Dkk family, which inhibits the Wnt signaling pathway by interacting with the LRP5/6 receptor and promotes lysosome endocytosis (14,15). Although it has not been as well studied as Wnt, the Dkk3 gene has been shown to be downregulated in prostate tumor cells (16), suggesting that increased Dkk3 expression may inhibit tumor cells development (17). In the present study, TP-treated rats exhibited downregulated Dkk3 expression compared with the control group. As it is known that TP induces BPH, it may be concluded that downregulation of the Dkk3 gene reduces the inhibition of cell proliferation and cell differentiation, in addition to causing BPH (18).

Tgm4 is a gene involved in the AR signaling pathway and is expressed in normal and abnormal prostate tissues. In numerous studies, Tgm4 has been shown to be a candidate marker for prostate cells (19,20). In the TP group, Tgm4 upregulation promoted prostate cell proliferation. Additionally, TP treatment resulted in the downregulation of Fas, resulting in reduced apoptosis (21), and therefore enhanced prostate cell proliferation.

Ran is a member of RAS family and has been shown to be involved in the androgen signaling pathway in addition to the regulation of DNA transcription (22). Although numerous studies have investigated the association between Ran and prostate cancer (23), more recent studies have investigated Ran in the context of benign proliferation of prostate cells (24,25). In the present study, the upregulation of the Ran gene was confirmed using RT-PCR, and the results suggested that Ran upregulation may contribute to prostate cell proliferation in BPH.

AR serves a crucial function in the prostate and is coregulated by hormone/receptor combinations (26). Previous studies have demonstrated that numerous coregulatory events are associated with the Ras family. Furthermore, recent studies have reported that Ras response element binding protein 1 (RREB-1) is a ligand for AR and coregulates AR. Therefore, this Ras-associated protein has the potential to inhibit AR function. The Ras/MAPK kinase pathway is able to counteract RREB-1, inhibiting the androgen signaling pathway (27). As a member of the Ras family, Ran is involved in this inhibitory process and functions to promote prostate cell proliferation. In addition, Ran is involved in mitotic spindle organization and biogenesis, which may affect mitotic orientation of epithelial cells. In Ras-mediated transformation, Krüppel-like factor 5 regulates the cyclin B1/Cdc2 proteins, in addition to activating the cell cycle, and thereby promotes cell mitosis (27,28). Thus, collectively, the present data suggest that TP treatment altered the mitotic orientation of prostate epithelial cells via a pathway involving Wnt and AR signaling. Further studies are required to determine the precise mechanisms through which Krüppel-like factor 5 is involved in this process.

In conclusion, mitotic reorientation of rat prostate epithelial cells was altered following exposure to subchronic TP, which may have promoted prostate cell proliferation via the Wnt and AR signaling pathways.

Acknowledgements

This study was supported by grants from the New Drug Major Program of China (no. 2011ZX09301-005), the National Natural Science Foundation of China (no. 11101077), the Shanghai ‘Science and Technology Innovation Action Plan’ Experimental Animal Research Project (nos. 11140901300 and 11140901302) and the Shanghai Key Lab of Human Performance (Shanghai University of Sport) (grant no. 11DZ2261100). The authors would like to thank Miss Dong-Mei Li, Mr. Lei Wang, Mr. Gui-Lin He, Professor Xiu-Rong Jiang, Professor Gui-Ming Liu, Dr Shu-Wu Xie, Dr Zhi-Ling Li and Dr Li Ma for their technical assistance.

Glossary

Abbreviations

Abbreviations:

AR

androgen receptor

TP

testosterone propionate

BPH

benign prostate hyperplasia

H&E

hematoxylin and eosin

Pca

prostatic carcinoma

RT-PCR

reverse transcription-polymerase chain reaction

SD

Sprague-Dawley

References

1 

Berry SJ, Coffey DS, Walsh PC and Ewing LL: The development of human benign prostatic hyperplasia with age. J Urol. 132:474–479. 1984.PubMed/NCBI

2 

Liu XY, Li DM, Zhang XF, Wu JH and Sun ZY: Mitosis orientation in prostate epithelial cells changed by endocrine effect. Acta Pharmacol Sin. 29:226–229. 2008. View Article : Google Scholar : PubMed/NCBI

3 

Gao W: Androgen receptor as a therapeutic target. Adv Drug Deliv Rev. 62:1277–1284. 2010. View Article : Google Scholar : PubMed/NCBI

4 

Chatterjee B: The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer. Mol Cell Biochem. 253:89–101. 2003. View Article : Google Scholar : PubMed/NCBI

5 

Beltrami AP, Cesselli D and Beltrami CA: At the stem of youth and health. Pharmacol Ther. 129:3–20. 2011. View Article : Google Scholar : PubMed/NCBI

6 

Isaacs JT and Coffey DS: Etiology and disease process of benign prostatic hyperplasia. Prostate Suppl. 2:33–50. 1989. View Article : Google Scholar : PubMed/NCBI

7 

Mansour FH and Pestov DG: Separation of long RNA by agarose-formaldehyde gel electrophoresis. Anal Biochem. 441:18–20. 2013. View Article : Google Scholar : PubMed/NCBI

8 

Vignozzi L, Gacci M, Cellai I, Santi R, Corona G, Morelli A, Rastrelli G, Comeglio P, Sebastanelli A, Maneschi E, et al: Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation. Prostate. 73:789–800. 2013. View Article : Google Scholar : PubMed/NCBI

9 

Xiang-Yun L, Ying-Wen X, Chen-Jing X, Jiu-Jiu W, Qi P, Bo G and Zu-Yue S: Possible mechanism of benign prostatic hyperplasia induced by androgen-estrogen ratios in castrated rats. Indian J Pharmacol. 42:312–317. 2010. View Article : Google Scholar : PubMed/NCBI

10 

Hartman J, Ström A and Gustafsson JÅ: Current concepts and significance of estrogen receptor β in prostate cancer. Steroids. 77:1262–1266. 2012. View Article : Google Scholar : PubMed/NCBI

11 

Logan CY and Nusse R: The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol. 20:781–810. 2004. View Article : Google Scholar : PubMed/NCBI

12 

Polakis P: Wnt signaling and cancer. Genes Dev. 14:1837–1851. 2000.PubMed/NCBI

13 

Ye X, Zerlanko B, Kennedy A, Banumathy G, Zhang R and Adams PD: Downregulation of Wnt signaling is a trigger for formation of facultative heterochromatin and onset of cell senescence in primary human cells. Mol Cell. 27:183–196. 2007. View Article : Google Scholar : PubMed/NCBI

14 

Levasseur R, Lacombe D and de Vernejoul MC: LRP5 mutations in osteoporosis-pseudoglioma syndrome and high-bone-mass disorders. Joint Bone Spine. 72:207–214. 2005. View Article : Google Scholar : PubMed/NCBI

15 

Davidson G, Mao B, del Barco Barrantes I and Niehrs C: Kremen proteins interact with Dickkopf1 to regulate anteroposterior CNS patterning. Development. 129:5587–5596. 2002. View Article : Google Scholar : PubMed/NCBI

16 

Abarzua F, Sakaguchi M, Takaishi M, Nasu Y, Kurose K, Ebara S, Miyazaki M, Namba M, Kumon H and Huh NH: Adenovirus-mediated overexpression of REIC/Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2-kinase. Cancer Res. 65:9617–9622. 2005. View Article : Google Scholar : PubMed/NCBI

17 

Hsieh SY, Hsieh PS, Chiu CT and Chen WY: Dickkopf-3/REIC functions as a suppressor gene of tumor growth. Oncogene. 23:9183–9189. 2004.PubMed/NCBI

18 

Kawano Y, Kitaoka M, Hamada Y, Walker MM, Waxman J and Kypta RM: Regulation of prostate cell growth and morphogenesis by Dickkopf-3. Oncogene. 25:6528–6537. 2006. View Article : Google Scholar : PubMed/NCBI

19 

Li H, Wu C, Gu X and Xiong C: A novel application of cell-free seminal mRNA: Non-invasive identification of the presence of germ cells or complete obstruction in men with azoospermia. Hum Reprod. 27:991–997. 2012. View Article : Google Scholar : PubMed/NCBI

20 

Xu B, Harihan A, Rakshit S, Dressler GR and Wellik DM: The role of Pax2 in mouse prostate development. Prostate. 72:217–224. 2012. View Article : Google Scholar : PubMed/NCBI

21 

Thielen JL, Volzing KG, Collier LS, Green LE, Largaespada DA and Marker PC: Markers of prostate region-specific epithelial identity define anatomical locations in the mouse prostate that are molecularly similar to human prostate cancers. Differentiation. 75:49–61. 2007. View Article : Google Scholar : PubMed/NCBI

22 

Ran L, He W, Zhu X, Zhou Q and Gou X: Comparison of fluid absorption between transurethral enucleation and transurethral resection for benign prostate hyperplasia. Urol Int. 91:26–30. 2013. View Article : Google Scholar : PubMed/NCBI

23 

Newton CJ, Ran G, Xie YX, Bilko D, Burgoyne CH, Adams I, Abidia A, McCollum PT and Atkin SL: Statin-induced apoptosis of vascular endothelial cells is blocked by dexamethasone. J Endocrinol. 174:7–16. 2002. View Article : Google Scholar : PubMed/NCBI

24 

Niehrs C and Acebron SP: Mitotic and mitogenic Wnt signalling. EMBO J. 31:2705–2713. 2012. View Article : Google Scholar : PubMed/NCBI

25 

Nandan MO, Chanchevalap S, Dalton WB and Yang VW: Krüppel-like factor 5 promotes mitosis by activating the cyclin B1/Cdc2 complex during oncogenic Ras-mediated transformation. FEBS Lett. 579:4757–4762. 2005. View Article : Google Scholar : PubMed/NCBI

26 

Antonarakis ES, Lu C, Luber B, Wang H, Chen Y, Nakazawa M, Nadal R, Paller CJ, Denmeade SR, Carducci MA, et al: Androgen receptor splice variant 7 and efficacy of taxane chemotherapy in patients with metastatic castration-resistant prostate cancer. JAMA Oncol. 1:582–591. 2015. View Article : Google Scholar : PubMed/NCBI

27 

Mukhopadhyay NK, Cinar B, Mukhopadhyay L, Lutchman M, Ferdinand AS, Kim J, Chung LW, Adam RM, Ray SK, Leiter AB, et al: The zinc finger protein ras-responsive element binding protein-1 is a coregulator of the androgen receptor: Implications for the role of the Ras pathway in enhancing androgenic signaling in prostate cancer. Mol Endocrinol. 21:2056–2070. 2007. View Article : Google Scholar : PubMed/NCBI

28 

Choi HJ and Zhu BT: Critical role of cyclin B1/Cdc2 up-regulation in the induction of mitotic prometaphase arrest in human breast cancer cells treated with 2-methoxyestradiol. Biochim Biophys Acta. 1823:1306–1315. 2012. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Liu X, Cheng Y, Pan Q, Hu W, Xu L, Meng X, Wu J, Xie C, Yan H, Sun Z, Sun Z, et al: Changes in mitotic reorientation and Wnt/AR signaling in rat prostate epithelial cells exposed to subchronic testosterone. Exp Ther Med 11: 1361-1366, 2016.
APA
Liu, X., Cheng, Y., Pan, Q., Hu, W., Xu, L., Meng, X. ... Sun, Z. (2016). Changes in mitotic reorientation and Wnt/AR signaling in rat prostate epithelial cells exposed to subchronic testosterone. Experimental and Therapeutic Medicine, 11, 1361-1366. https://doi.org/10.3892/etm.2016.3044
MLA
Liu, X., Cheng, Y., Pan, Q., Hu, W., Xu, L., Meng, X., Wu, J., Xie, C., Yan, H., Sun, Z."Changes in mitotic reorientation and Wnt/AR signaling in rat prostate epithelial cells exposed to subchronic testosterone". Experimental and Therapeutic Medicine 11.4 (2016): 1361-1366.
Chicago
Liu, X., Cheng, Y., Pan, Q., Hu, W., Xu, L., Meng, X., Wu, J., Xie, C., Yan, H., Sun, Z."Changes in mitotic reorientation and Wnt/AR signaling in rat prostate epithelial cells exposed to subchronic testosterone". Experimental and Therapeutic Medicine 11, no. 4 (2016): 1361-1366. https://doi.org/10.3892/etm.2016.3044
Copy and paste a formatted citation
x
Spandidos Publications style
Liu X, Cheng Y, Pan Q, Hu W, Xu L, Meng X, Wu J, Xie C, Yan H, Sun Z, Sun Z, et al: Changes in mitotic reorientation and Wnt/AR signaling in rat prostate epithelial cells exposed to subchronic testosterone. Exp Ther Med 11: 1361-1366, 2016.
APA
Liu, X., Cheng, Y., Pan, Q., Hu, W., Xu, L., Meng, X. ... Sun, Z. (2016). Changes in mitotic reorientation and Wnt/AR signaling in rat prostate epithelial cells exposed to subchronic testosterone. Experimental and Therapeutic Medicine, 11, 1361-1366. https://doi.org/10.3892/etm.2016.3044
MLA
Liu, X., Cheng, Y., Pan, Q., Hu, W., Xu, L., Meng, X., Wu, J., Xie, C., Yan, H., Sun, Z."Changes in mitotic reorientation and Wnt/AR signaling in rat prostate epithelial cells exposed to subchronic testosterone". Experimental and Therapeutic Medicine 11.4 (2016): 1361-1366.
Chicago
Liu, X., Cheng, Y., Pan, Q., Hu, W., Xu, L., Meng, X., Wu, J., Xie, C., Yan, H., Sun, Z."Changes in mitotic reorientation and Wnt/AR signaling in rat prostate epithelial cells exposed to subchronic testosterone". Experimental and Therapeutic Medicine 11, no. 4 (2016): 1361-1366. https://doi.org/10.3892/etm.2016.3044
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team